Sign in

CIK 0001534120

  • Non-accelerated filer
  • Smaller reporting company

Avalo Therapeutics, Inc.

Sign in to watch
Ticker
AVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450705648
Phone
+1 410-522-8707
Business address
1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
Former names
Cerecor Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$395,474
in 3 filings, $395K under 10b5-1 plans

Net −$395,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-08-23 Phillips Matthew V Chief Commercial Officer Grant or award +512,500 $1.07 $548K 512,500
2019-06-10 Phillips Matthew V Chief Commercial Officer Purchase +523 $2.85 $1K 1,020
2019-04-01 Phillips Matthew V Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +145,000 145,000
2018-12-10 Phillips Matthew V Chief Commercial Officer Purchase +497 $2.85 $1K 497
2018-01-22 Phillips Matthew V Chief Commercial Officer Grant or award · Stock Option (right to buy) +100,000 100,000

Page 1 of 1 · 5 trades